Form 4 for SABS SAB Biotherapeutics, Inc.
Accepted 2022-09-08 00:00:00 ET · period of report 2022-09-07 · accession 0001209191-22-049168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-08 | 2022-09-07 | SABS | Sullivan Eddie Joe | CEO, Dir, 10% | P - Purchase | $0.74 | +14.0K | 5.23M | +0.3% | +$10.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-07 | P | A | 14,000 | $0.74 | 5,230,564 | D | — | — |